The Georgia Cancer Center is advancing public, patient, and professional education and cancer-related training throughout the enterprise and in the community it serves in several important ways.
The Georgia Cancer Center strives to advance the field by training the next generation of physicians and scientists in oncology. The Cancer Center is an active participant in Augusta University training programs, from graduate programs to postdoctoral training in both research and clinical care. Committed to the future workforce of cancer researchers and clinicians, the Georgia Cancer Center is involved in leading two PhD graduate and two medical fellowship programs.
All students and trainees enrolled in these programs are considered to be Emerging Biomedical Professionals (EBPs) and are welcome to participate in various EBP programming.
The Division of Hematology and Oncology offers an ACGME-accredited postgraduate fellowship training program designed to prepare trainees to evaluate, understand, and manage complex hematological and oncological disorders.
The comprehensive combined training program prepares fellows for independent clinical practice and eligibility for the ABIM subspecialty board examinations. In addition to rigorous clinical training, the program strives to create an atmosphere of scientific curiosity and endeavor. Both Augusta University Health and the Georgia Cancer Center training sites offer a wide breadth of clinical and research experience. The program boasts a diverse tumor-specific clinical core-faculty dedicated to teaching, an aggressive didactic program, and a plethora of research opportunities with world-renowned researchers at the Georgia Cancer Center, the Hemophilia Treatment Center, and Sickle Cell Center.
The Hereditary Cancer Clinic (HCC) at the Georgia Cancer Center offers a new, 12- month advanced fellowship in hereditary cancer knowledge, clinical practice, program development, and research.
The HCC has a rapidly growing program in genetics and cancer risk management, with over 1,000 new patient referrals expected in 2024 with a 25% positive test rate. HCC practitioners conduct an analysis of personal and family cancer history and order genetic testing, followed by comprehensive cancer genetic risk assessment for those whose tests reveal the presence of a monogenic disorder.
Kevin Hughes, MD
843-792-9300
The Gynecologic Oncology Fellowship at the Medical College of Georgia at Augusta University was approved by the ACGME on February 9, 2017, and is currently the only approved Gynecologic Oncology Fellowship in the state of Georgia.
This is a three-year fellowship with one fellow position per year. The objective of the fellowship program is to produce well-rounded gynecologic oncologists to provide excellent clinical care for women with regards to the prevention, detection, and treatment of gynecologic malignancies.
Sharad Ghamande, MD
Bunja Rungruang, MD
Robert Higgins, MD
Marian Symmes Johnson, MD
Romona Cumbermack